nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—PGR—Betamethasone—psoriasis	0.209	0.392	CbGbCtD
Allylestrenol—Levonorgestrel—Hydrocortisone—psoriasis	0.129	0.279	CrCrCtD
Allylestrenol—PGR—Dexamethasone—psoriasis	0.121	0.228	CbGbCtD
Allylestrenol—Norethindrone—Hydrocortisone—psoriasis	0.104	0.224	CrCrCtD
Allylestrenol—Methyltestosterone—Hydrocortisone—psoriasis	0.085	0.184	CrCrCtD
Allylestrenol—Methyltestosterone—Prednisone—psoriasis	0.0732	0.158	CrCrCtD
Allylestrenol—Methyltestosterone—Prednisolone—psoriasis	0.0714	0.155	CrCrCtD
Allylestrenol—CYP3A4—Calcitriol—psoriasis	0.0388	0.0728	CbGbCtD
Allylestrenol—CYP3A4—Methoxsalen—psoriasis	0.0302	0.0566	CbGbCtD
Allylestrenol—CYP3A4—Cholecalciferol—psoriasis	0.02	0.0375	CbGbCtD
Allylestrenol—CYP3A4—Mycophenolate mofetil—psoriasis	0.0173	0.0325	CbGbCtD
Allylestrenol—CYP3A4—Triamcinolone—psoriasis	0.0173	0.0325	CbGbCtD
Allylestrenol—CYP3A4—Betamethasone—psoriasis	0.0149	0.0279	CbGbCtD
Allylestrenol—CYP3A4—Prednisolone—psoriasis	0.0147	0.0275	CbGbCtD
Allylestrenol—CYP3A4—Hydrocortisone—psoriasis	0.0139	0.0261	CbGbCtD
Allylestrenol—CYP3A4—Prednisone—psoriasis	0.0139	0.026	CbGbCtD
Allylestrenol—CYP3A4—Cyclosporine—psoriasis	0.0131	0.0247	CbGbCtD
Allylestrenol—CYP3A4—Dexamethasone—psoriasis	0.00865	0.0162	CbGbCtD
Allylestrenol—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.000214	0.0433	CbGpPWpGaD
Allylestrenol—PGR—Ovarian Infertility Genes—VDR—psoriasis	0.000195	0.0394	CbGpPWpGaD
Allylestrenol—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000186	0.0376	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptors—VDR—psoriasis	0.00017	0.0343	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000154	0.0311	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000134	0.0271	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptors—PPARG—psoriasis	0.000118	0.0239	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000116	0.0235	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000107	0.0216	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000101	0.0203	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptors—VDR—psoriasis	9.97e-05	0.0201	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	9.94e-05	0.0201	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—REL—psoriasis	9.84e-05	0.0199	CbGpPWpGaD
Allylestrenol—PGR—Cellular roles of Anthrax toxin—TNF—psoriasis	9.74e-05	0.0197	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptor transcription pathway—PPARG—psoriasis	9.36e-05	0.0189	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	8.59e-05	0.0174	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	7.94e-05	0.016	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	7.88e-05	0.0159	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.73e-05	0.0156	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.63e-05	0.0154	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen signaling pathway—JUN—psoriasis	7.37e-05	0.0149	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	7.09e-05	0.0143	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptors—PPARG—psoriasis	6.95e-05	0.014	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.27e-05	0.0127	CbGpPWpGaD
Allylestrenol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	6.18e-05	0.0125	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5.97e-05	0.0121	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL10—psoriasis	5.95e-05	0.012	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—TARS—psoriasis	5.94e-05	0.012	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	5.83e-05	0.0118	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL4—psoriasis	5.79e-05	0.0117	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	5.54e-05	0.0112	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	5.49e-05	0.0111	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	5.44e-05	0.011	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	5.29e-05	0.0107	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	5.27e-05	0.0106	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	5.24e-05	0.0106	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	5.23e-05	0.0106	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—LEP—psoriasis	4.63e-05	0.00935	CbGpPWpGaD
Allylestrenol—ESR1—FOXA1 transcription factor network—JUN—psoriasis	4.38e-05	0.00885	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.07e-05	0.00823	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	4.01e-05	0.0081	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—CARM1—psoriasis	3.88e-05	0.00784	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	3.73e-05	0.00753	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.7e-05	0.00747	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—IFNG—psoriasis	3.58e-05	0.00723	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.55e-05	0.00717	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IFNG—psoriasis	3.5e-05	0.00706	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—TARS—psoriasis	3.49e-05	0.00704	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	3.48e-05	0.00702	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—JUN—psoriasis	3.47e-05	0.007	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—TYK2—psoriasis	3.42e-05	0.00691	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.33e-05	0.00673	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.28e-05	0.00663	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	3.25e-05	0.00657	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	3.25e-05	0.00656	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.17e-05	0.0064	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—JUN—psoriasis	3.09e-05	0.00625	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—JUN—psoriasis	3.02e-05	0.00611	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—NFKB1—psoriasis	2.98e-05	0.00602	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—TP53—psoriasis	2.95e-05	0.00595	CbGpPWpGaD
Allylestrenol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.87e-05	0.0058	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—NFKB1—psoriasis	2.75e-05	0.00556	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HCAR2—psoriasis	2.75e-05	0.00556	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	2.69e-05	0.00543	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.48e-05	0.005	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—STAT3—psoriasis	2.48e-05	0.005	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.43e-05	0.00491	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TAGAP—psoriasis	2.39e-05	0.00482	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—VDR—psoriasis	2.32e-05	0.00468	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—CARM1—psoriasis	2.28e-05	0.0046	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—IL6—psoriasis	2.09e-05	0.00423	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.04e-05	0.00413	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—TYK2—psoriasis	2.01e-05	0.00406	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—TP53—psoriasis	2e-05	0.00403	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—CARM1—psoriasis	1.87e-05	0.00378	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL6—psoriasis	1.83e-05	0.00369	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—IL6—psoriasis	1.67e-05	0.00338	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.63e-05	0.0033	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—PPARG—psoriasis	1.62e-05	0.00326	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HCAR2—psoriasis	1.62e-05	0.00326	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.57e-05	0.00318	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL20—psoriasis	1.43e-05	0.00289	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.43e-05	0.00288	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TAGAP—psoriasis	1.4e-05	0.00283	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—VDR—psoriasis	1.36e-05	0.00275	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.35e-05	0.00274	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.3e-05	0.00263	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.18e-05	0.00239	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—VDR—psoriasis	1.12e-05	0.00225	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CARM1—psoriasis	1.1e-05	0.00222	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.08e-05	0.00218	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.01e-05	0.00205	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—IL6—psoriasis	9.83e-06	0.00198	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PPARG—psoriasis	9.49e-06	0.00192	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.94e-06	0.00181	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL20—psoriasis	8.39e-06	0.00169	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SOCS1—psoriasis	7.87e-06	0.00159	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PPARG—psoriasis	7.78e-06	0.00157	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NDUFA5—psoriasis	6.7e-06	0.00135	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—VDR—psoriasis	6.55e-06	0.00132	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LEP—psoriasis	5.81e-06	0.00117	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOE—psoriasis	5.81e-06	0.00117	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2S1—psoriasis	5.7e-06	0.00115	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NFKBIA—psoriasis	5.41e-06	0.00109	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SOCS1—psoriasis	4.62e-06	0.000933	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPARG—psoriasis	4.57e-06	0.000923	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TYK2—psoriasis	4.43e-06	0.000896	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL8—psoriasis	3.86e-06	0.00078	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—JUN—psoriasis	3.59e-06	0.000725	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NFKB1—psoriasis	3.45e-06	0.000698	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LEP—psoriasis	3.41e-06	0.000689	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOE—psoriasis	3.41e-06	0.000689	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NFKBIA—psoriasis	3.18e-06	0.000642	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—psoriasis	3.14e-06	0.000633	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—STAT3—psoriasis	3.1e-06	0.000627	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CARM1—psoriasis	2.78e-06	0.000562	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TYK2—psoriasis	2.6e-06	0.000526	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TP53—psoriasis	2.37e-06	0.000478	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL8—psoriasis	2.27e-06	0.000458	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL6—psoriasis	2.17e-06	0.000438	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—JUN—psoriasis	2.11e-06	0.000425	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NFKB1—psoriasis	2.03e-06	0.00041	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—psoriasis	1.84e-06	0.000372	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—STAT3—psoriasis	1.82e-06	0.000368	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CAT—psoriasis	1.71e-06	0.000345	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TP53—psoriasis	1.39e-06	0.000281	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOE—psoriasis	1.33e-06	0.000268	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL6—psoriasis	1.27e-06	0.000257	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARG—psoriasis	1.16e-06	0.000234	CbGpPWpGaD
